The cervical high risk HPV infection
Conditions
Interventions
Experimental group:Bao fu Kang Shuan
Sponsors
Guangan men Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
Female
Age
30 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. In line with the western medicine type cervical high risk HPV infection diagnosis, TCM syndrome differentiation for damp heat stasis syndrome; 2. Sexual life history, Age 30 to 55; 3. Cervical cytology test results is normal/inflammatory reaction or ASC - US/LSIL histopathological examination results for inflammation; 4. 6 months to 12 months prior to screening cervix high-risk type HPV HC2 inspecting at least 1 time for positive people; 5. Voluntary signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Genital tract inflammation (gonorrhea, chlamydia, Candida vaginitis, Trichomonas vaginitis, Bacterial vaginal disease Etc.); 2. In patients with CIN I-III; 3. Pregnancy, lactation, or intention of pregnancy women; 4. Patients of the womb; 5. The menopause women irregular menstruation, Including the period is more than 7 days or menstrual cycle less than 25 days or menstrual cycle more than 35 days; 6. A weakened immune system (Radiation andchemotherapy after, AIDS, SLE Etc.); 7. Laboratory results: ALT, AST more than The upper limit of normal by 1.5 times, Creatinine than normal ceiling; 8. People with diabetes; 9. Nearly three months by oral contraceptive birth control; 10. With cardiovascular, cerebrovascular, liver, kidney andhematopoietic system andother serious primary diseases andpsychiatric patients; 11. Allergic constitution or preserved woman Kang Shuan allergy drug ingredients; 12. Nearly three months treatment of HPV infection measures; 13. Nearly three months in other clinical trials; 14. Doubt or have alcohol anddrug abuse history, or according to the researchers judgement, can reduce the set of possibilities or complicate the group or other lesions, such as working environment change often, living environment is not stable, easy to cause lost to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Negative conversion ratio of cervical high-risk HPV DNA; | — |
Secondary
| Measure | Time frame |
|---|---|
| Negative conversion ratio of cervical high-risk HPV DNA in the 8 months;Individual symptom scores;Improvement rate of cervical high-risk HPV DNA;TCM syndrome score; | — |
Countries
China
Contacts
Public ContactRen Yujing
Outcome results
None listed